Form 4 Filing for CervoMed Inc. - Poulton Jeffrey V. Granted Stock Options

This filing reports the grant of stock options to Jeffrey V. Poulton, a director of CervoMed Inc., on June 8, 2026. In connection with his election to the board, Poulton was granted an option to purchase 8,150 shares of the Issuer's common stock under the Issuer's 2025 Equity Incentive Plan. The options are exercisable at a price of $2.91 per share and will vest monthly over one year, starting June 30, 2026, provided Poulton continues his service. The options have an expiration date of June 8, 2036. This transaction is classified as the acquisition of securities under a compensatory plan.